Advice on the use of Endo-SPONGE for colorectal anastomotic leakage to aid local decision making
Advice on the use of superDimension Navigation System to help diagnostic sampling of peripheral lung lesions to aid local decision making
Advice on the use of MR-proADM test for use with clinical deterioration scores in cases of suspected infection to aid local decision making
Summary of the evidence on doxylamine/pyridoxine (Xonvea) for treating nausea and vomiting of pregnancy in women aged 18 years and older to inform local NHS
Advice on the use of HemaClear for bloodless surgical field during limb surgery to aid local decision making
Advice on the use of the OPTIMIZER smart system for managing heart failure to aid local decision making
Advice on the use of Danis stent for acute oesophageal variceal bleeds to aid local decision making
KTT24 Suicide prevention: optimising medicines and reducing access to medicines as a means of suicide Key points
KTT23 Shared decision making Key points In the context of medicines optimisation, shared
Advice on the use of DyeVert for reducing contrast media in coronary and peripheral angiography to aid local decision making
Advice on the use of Leukomed Sorbact for preventing surgical site infection (SSI) to aid local decision making
Advice on the use of Alpha-Stim AID for anxiety to aid local decision making
Advice on the use of the V.A.C. Veraflo Therapy system for infected wounds to aid local decision making
Advice on the use of InterDry for intertrigo (inflammatory skin rash) to aid local decision making
Advice on the use of UroShield for preventing catheter-associated urinary tract infections (CAUTI) to aid local decision making
Advice on the use of SuperNO2VA for the relief of upper airway obstruction in people with obstructive sleep apnoea to aid local decision making
KTT22 Chemotherapy dose standardisation Key points Chemotherapy dose standardisation
KTT19 Psychotropic medicines in people with learning disabilities whose behaviour challenges Key points
KTT20 Safer insulin prescribing Key points Several new insulin products have been launched
KTT12 Type 2 diabetes mellitus: medicines optimisation priorities Key points The NICE
KTT18 Multimorbidity and polypharmacy Key points Multimorbidity is associated with
KTT5 Asthma: medicines safety priorities Key points Inhaled corticosteroids (ICS) are
KTT9 Antimicrobial stewardship: prescribing antibiotics Key points Antimicrobial resistance
KTT16 Anticoagulants, including direct-acting oral anticoagulants (DOACs) Key points
KTT3 Lipid-modifying drugs Key points The NICE guideline on cardiovascular disease:
KTT7 Antipsychotics in people living with dementia Key points The risks and limited
KTT14 Wound care products Key points A large number of wound dressings are available
KTT17 Acute kidney injury (AKI): use of medicines in people with or at increased risk of AKI Key points
KTT6 Hypnotics Key points The risks associated with hypnotics (including melatonin)
KTT21 Medicines optimisation in chronic pain Key points Controlling chronic pain can
This guideline covers assessing and managing motor neurone disease (MND). It aims to improve care from the time of diagnosis, and covers information and support, organisation of care, managing symptoms and preparing for end of life care.
This guideline covers identifying and managing familial hypercholesterolaemia (FH), a specific type of high cholesterol that runs in the family, in children, young people and adults. It aims to help identify people at increased risk of coronary heart disease as a result of having FH.
This guideline covers the initial assessment of symptoms and signs that might indicate a neurological condition. It helps non-specialist healthcare professionals to identify people who should be offered referral for specialist investigation.
This guideline covers assessing and managing urinary incontinence and pelvic organ prolapse in women aged 18 and over. It also covers complications associated with mesh surgery for these conditions.
This guideline covers the care of women at increased risk of, or with symptoms and signs of, preterm labour (before 37 weeks), and women having a planned preterm birth. It aims to reduce the risks of preterm birth for the baby and describes treatments to prevent or delay early labour and birth.
This guideline covers long-acting reversible contraception. It aims to increase the use of long-action reversible contraception by improving the information given to women about their contraceptive choices.
This guideline covers diagnosing and managing chronic obstructive pulmonary disease or COPD (which includes emphysema and chronic bronchitis) in people aged 16 and older. It aims to help people with COPD to receive a diagnosis earlier so that they can benefit from treatments to reduce symptoms, improve quality of life and keep them healthy for longer.
This guideline covers the care and treatment of people aged 18 and over with generalised anxiety disorder (chronic anxiety) or panic disorder (with or without agoraphobia or panic attacks). It aims to help people achieve complete relief of symptoms (remission), which is associated with better functioning and a lower likelihood of relapse.
This guideline covers interventions in secondary and further education to prevent and reduce alcohol use among children and young people aged 11 up to and including 18. It also covers people aged 11 to 25 with special educational needs or disabilities in full-time education. It will also be relevant to children aged 11 in year 6 of primary school.
This guideline covers identifying and managing depression in children and young people aged 5 to 18 years. Based on the stepped-care model, it aims to improve recognition and assessment and promote effective treatments for mild and moderate to severe depression.
This guideline covers diagnosing and managing hypertension (high blood pressure), including pre-eclampsia, during pregnancy, labour and birth. It also includes advice for women with hypertension who wish to conceive and women who have had a pregnancy complicated by hypertension. It aims to improve care during pregnancy, labour and birth for women and their babies.
This guideline covers care for women of any age (including girls and young women under 18) who request an abortion. It aims to improve the organisation of services and make them easier for women to access. Detailed recommendations on conducting abortions at different gestational stages are also included, to ensure that women get the safest and most effective care possible.
This guideline covers prescribing of cannabis-based medicinal products for people with intractable nausea and vomiting, chronic pain, spasticity and severe treatment-resistant epilepsy.
This guideline covers the assessment and early management of fever with no obvious cause in children aged under 5. It aims to improve clinical assessment and help healthcare professionals diagnose serious illness among young children who present with fever in primary and secondary care.
This guideline sets out an antimicrobial prescribing strategy for adults, young people, children and babies aged 72 hours and over with cellulitis and erysipelas. It aims to optimise antibiotic use and reduce antibiotic resistance.
This guideline covers organising and delivering end of life care services, which provide care and support in the final weeks and months of life (or for some conditions, years), and the planning and preparation for this. It aims to ensure that people have access to the care that they want and need in all care settings. It also includes advice on services for carers.
This guideline covers preventing, identifying and managing latent and active tuberculosis (TB) in children, young people and adults. It aims to improve ways of finding people who have TB in the community and recommends that everyone under 65 with latent TB should be treated. It describes how TB services should be organised, including the role of the TB control board.
This guideline covers preventing and managing foot problems in children, young people and adults with diabetes. It aims to reduce variation in practice, including antibiotic prescribing for diabetic foot infections.
This guideline covers investigating and managing gastro-oesophageal reflux disease (GORD) and dyspepsia in people aged 18 and over. It aims to improve the treatment of GORD and dyspepsia by making detailed recommendations on Helicobacter pylori eradication, and specifying when to consider laparoscopic fundoplication and referral to specialist services.
This guideline covers the assessment and early management of head injury in children, young people and adults. It promotes effective clinical assessment so that people receive the right care for the severity of their head injury, including referral directly to specialist care if needed.